Cargando…
Long Term Outcome and Histologic Findings of a Retinal Astrocytic Hamartoma Treated with Intravitreal Injection of Anti-VEGF: A Case Report
BACKGROUND: To our knowledge, this is the first report to describe the histologic changes of a retinal astrocytic hamartoma (RAH) in a patient with tuberous sclerosis complex (TSC) treated with antivascular endothelial growth factor (anti-VEGF), as well as the longest anti-VEGF treatment that such a...
Autores principales: | Ahmad, Kinza T., Mansour, Hana A., Rollins, Benjamin T., Oviedo, Sergio Pina, Phillips, Paul H., Uwaydat, Sami H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8486559/ https://www.ncbi.nlm.nih.gov/pubmed/34603809 http://dx.doi.org/10.1155/2021/7500791 |
Ejemplares similares
-
Retinal astrocytic hamartoma and Bourneville's disease
por: Ali, Mohammad Javed, et al.
Publicado: (2012) -
Retinal Astrocytic Hamartoma in Tuberous Sclerosis
por: Mishra, Chitaranjan, et al.
Publicado: (2019) -
Familial exudative vitreoretinopathy associated with retinal astrocytic hamartoma
por: Fan, Jason, et al.
Publicado: (2022) -
Rapid symptomatic and structural improvement of a retinal astrocytic hamartoma in response to anti-VEGF therapy: A case report
por: Allan, Kevin C., et al.
Publicado: (2022) -
Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections
por: Levin, Ariana M, et al.
Publicado: (2017)